NeuBase Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
18 Sep 2023	Form 4: Symetryx Corp, 10% owner Sold 129,108 shares ($186K) · Sold 103,337 shares ($130K) · Sold 50,000 shares ($59.5K)
11 Sep 2023	Form 4: Symetryx Corp, 10% owner Sold 74,852 shares ($135K) · Sold 128,847 shares ($197K) · Sold 3,376 shares ($4.86K)
07 Sep 2023	Form 4: Symetryx Corp, 10% owner Bought 61,076 shares ($59.7K)
04 Aug 2023	Form 4: Stephan Dietrich A, Director Received 93,234 shares by exercise or conversion ($2.05K)
17 Mar 2023	Form 4: Branning Todd P., Chief Financial Officer Received 54,200 shares as a grant or award
17 Mar 2023	Form 4: Stephan Dietrich A, Director Received 153,000 shares as a grant or award
15 Feb 2023	Form 4: Stephan Dietrich A, Director Received 655,000 shares by exercise or conversion
04 Nov 2022	Form 4: Branning Todd P., Chief Financial Officer Granted 200,000 Stock option (right to buy)
30 Sep 2022	Form 4: Stephan Dietrich A, Director Received 750,000 shares by exercise or conversion ($825)
12 Sep 2022	Form 4: Richman Eric I, Director Granted 37,600 Stock option (right to buy)
12 Sep 2022	Form 4: Prendergast Franklyn G, Director Granted 37,600 Stock option (right to buy)
12 Sep 2022	Form 4: McDougall Gerald J, Director Granted 37,600 Stock option (right to buy)
12 Sep 2022	Form 4: Goldstein Dov A Md, Director Granted 37,600 Stock option (right to buy)
12 Sep 2022	Form 4: Ende Eric J, Director Granted 37,600 Stock option (right to buy)
01 Apr 2022	Form 4: Mann William Roland, Chief Operating Officer Bought 6,200 shares ($11.9K)
21 Mar 2022	Form 4: Branning Todd P., Chief Financial Officer Bought 10,000 shares ($18.1K)
18 Mar 2022	Form 4: Branning Todd P., Chief Financial Officer Bought 10,000 shares ($16.2K) · Bought 10,000 shares ($17.4K)
07 Mar 2022	Form 4: Richman Eric I, Director Bought 1,580 shares ($2.5K) · Bought 1,300 shares ($2.24K) · Bought 1,000 shares ($1.62K)
25 Jan 2022	Form 4: Mann William Roland, Chief Operating Officer Granted 60,180 Employee stock option (right to buy)
25 Jan 2022	Form 4: Rojas-Caro Sandra, Chief Medical Officer Granted 44,592 Employee stock option (right to buy)

Comments